Exelixis makes counter-offer in proxy fight with hedge fund, will accept two new board members
About a week after hedge fund Farallon Capital Management went public with plans to launch a proxy fight against Exelixis, the biotech company said …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
